As expected, suppression of METTL16 expression augmented the growth and metastatic potential of PDA cells in vitro, whereas upregulation of METTL16 expression attenuated their proliferation and invasion capacity (Figures 4D–G). The gene discussed is METTL16; the disease is Patent ductus arteriosus.